Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy

BACKGROUND AND AIMS: A similar course of COVID-19 in patients with inflammatory bowel diseases (IBD) and in the general population has been reported. However, disease prevalence in IBD patients is presently unknown. In this prospective observational study we aimed at determining SARS-CoV2 infection...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Crohns Colitis
Hlavní autoři: Berte', Roberto, Mazza, Stefano, Stefanucci, Marta Rachele, Noviello, Daniele, Costa, Stefania, Ciafardini, Clorinda, Mileti, Erika, Mapelli, Marina, Pasqualato, Sebastiano, Pinto, Sergio, Favale, Agnese, Vecchi, Maurizio, Neurath, Markus F, Atreya, Raja, Fantini, Massimo Claudio, Facciotti, Federica, Caprioli, Flavio
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717179/
https://ncbi.nlm.nih.gov/pubmed/33211810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa237
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky